ArticleFrontiers in immunology2023

Complete and early response to cemiplimab associated to severe immune toxicity in advanced cervical cancer: a case report.

Anna Passarelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.